REGN
REGN
Strong downtrend on Eylea erosion
Price
Price at analysis
$609.81
The case
● Bull — what supports it
Dupixent strength, oversold; quality biotech at multi-year lows.
● Bear — what refutes it
STRONG_TREND_DOWN ADX 35, -21% 3m, Eylea US sales -36% YoY, PFS regulatory delays, lowered GM outlook.
What would change our mind
Drake commits in advance to what would prove this call wrong — falsifiers, not hindsight.
- Eylea stabilization / positive PFS regulatory update + ADX rolling over.
The verdict
Sector analyst (Drake panel)–neutral
conviction 0.55
- Strong downtrend on Eylea erosion
- Regulatory overhang on PFS
Risks: STRONG_TREND_DOWN ADX 35, -21% 3m, Eylea US sales -36% YoY, PFS regulatory delays, lowered GM outlook.
Forward-only: this call is graded against the future, on its resolution date — never backfilled. This run carries a single synthesized panel verdict; multi-specialist runs list each view above.